retatrutide trial news today Amid the growing demand for GLP-1 medications for weight loss, a new experimental drug, retatrutide, stands out, according to new clinical results released on Thursday., ABC News' Youri A New Obesity Drug Delivered

Still, compounded forms differ from FDA-approved branded products in testing and labeling

It contains 1,000 times more active GHK-Cu

Experimental: Not currently USP sourced or FDA approved (research use only high risk) Final Thoughts When Comparing different GLP-1 drugs including Semaglutide, retatrutide, and tirzepatide, its important to remember they are all medications used to manage obesity and type 2 diabetes, but they differ in their mechanisms and benefits

Your regular periods will return about three months after stopping these medications

After having bariatric surgery that didnt stop her cravings to eat more than she needed to, according to Erika, she started taking Victoza